BioStem Technologies Inc. (BSEM)
BSEM trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.25
-7.79% on the day
Market cap
$42.0M
Nano cap
Revenue · 2025
$47.5M
-31.8% on 2024
Net income · 2025
-$6.6M
-13.9% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | BSEM on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001658678 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | FL |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $47.5M |
| Net income | -$6.6M |
| Operating income | -$689K |
| Net margin | -13.9% |
| Operating margin | -1.5% |
| Revenue growth | -31.8% |
| Cash | $29.5M |
| Total assets | $50.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.9× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B3 | 2026-10-13 |
| Latest quarterly / interim | 10-Q | 2026-08-12 |
| Latest current report | 8-K | 2026-09-30 |
Source: SEC EDGAR submissions feed, 61 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TIL | Instil Bio Inc. | $6.18 | -6.08% | $41.9M |
| EXOZ | eXoZymes Inc. | $4.59 | -9.11% | $42.7M |
| INMB | INmune Bio Inc. | $1.68 | -5.62% | $46.6M |
| IMA | ImageneBio Inc. | $4.24 | -0.23% | $48.1M |
| CRBU | Caribou Biosciences Inc. | $0.4700 | -5.41% | $50.4M |
| GNTA | Genenta Science S.p.A. | $0.7220 | -4.99% | $34.8M |
| MGX | Metagenomi Therapeutics Inc. | $0.9173 | -10.07% | $34.7M |
| ELOX | Eloxx Pharmaceuticals Inc. | $12.70 | -8.57% | $51.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier